novartis ceo on the company's pledge to provide no-profit medicines to low-income countries
Published 4 years ago • 844 plays • Length 6:02Download video MP4
Download video MP3
Similar videos
-
3:45
novartis not joining the 'frenzy' of weight loss drugs, ceo says
-
3:29
innovative medicines business returning to growth, novartis ceo says
-
6:12
novartis ceo: expect continued growth in 2023
-
0:45
novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off
-
1:51
committed to growing over 4% through 2026, says novartis ceo
-
4:16
novartis ceo vas narasimhan: our medicines are starting to take market share and deliver on promises
-
7:51
watch cnbc's full interview with novartis ceo vas narasimhan
-
24:07
novartis ceo vas narasimhan on the david rubenstein show
-
6:11
ubs' thomas fang and the smart investor's david kuo debate china's stimulus promises
-
9:48
novartis ceo: growth drivers performing well, but product exclusivity losses creating headwinds
-
7:41
novartis ceo on company's approach to covid-19 treatment
-
3:29
novartis generated $40 billion in innovative medicine sales, says ceo
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
4:22
novartis ceo on new cancer therapy programs
-
3:47
novartis ceo: demand has surged for therapeutics
-
3:54
we should not rely on tariffs to make business, citroën ceo says
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
5:48
novartis acquires the medicines company for $9.7 billion
-
12:38
health care in a post-pandemic world with vas narasimhan novartis at cnbc evolve global summit 2021
-
3:04
novartis ceo: spinoffs will see us succeed as a pure-play innovative medicines company
-
4:54
novartis ceo: confident about continued sales growth for rest of year